Protein arginine methyltransferases (PRMTs) are overexpressed in many cancer types, including triple-negative breast cancer (TNBC). A new study shows that a reversible inhibitor of type I PRMTs suppresses TNBC tumor growth by inducing a viral mimicry response with retained introns.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tarantino, P. et al. NPJ Breast Cancer 8, 23 (2022).
Wu, Q. et al. Nat. Chem. Biol. https://doi.org/10.1038/s41589-022-01024-4 (2022).
Fedoriw, A. et al. Cancer Cell 36, 100–114 (2019).
Fong, J. Y. et al. Cancer Cell 36, 194–209 (2019).
Chiappinelli, K. B. et al. Cell 162, 974–986 (2015).
Roulois, D. et al. Cell 162, 961–973 (2015).
Srour, N. et al. Cell Rep. 38, 110582 (2022).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Srour, N., Richard, S. Putting introns on retainer. Nat Chem Biol 18, 795–796 (2022). https://doi.org/10.1038/s41589-022-01025-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41589-022-01025-3